SEC Form 4 · accession 0001209191-17-050892
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Aug 30, 2017
Accepted (ET)
Aug 31, 2017 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2017 | G | 10,000 | $0.00 | D | 339,368 | D | |
| Common StockF2 | Aug 30, 2017 | S | 25,667 | $115.1793 | D | 313,701 | D | |
| Common Stock | holding | — | — | — | 17,186 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- F2The range of prices for the transaction reported on this line was $115.00 to $115.75. The average weighted price was $115.1793. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.